News & Updates

Younger breast cancer survivors have better cognition, exercise habits than older survivors

Younger breast cancer survivors are more physically active and have better cognitive performance than their older counterparts, a new study has shown.

Gemcitabine plus albumin-bound paclitaxel useful for treating advanced SQCLC

The combination of gemcitabine plus albumin-bound paclitaxel (ABP) appears to be well tolerated and effective in the first-line treatment of patients with advanced squamous cell lung cancer (SQCLC), according to the results of a phase II study.

Ixekizumab COASTs through r-axSpA with sustained efficacy, safety

Two phase III trials reflect the sustained efficacy and safety of the bDMARD* ixekizumab in bDMARD-naïve (COAST-V) or TNFi**-experienced (COAST-W) adults with active radiographic axial spondyloarthritis (r-axSpA), also known as ankylosing spondylitis (AS).

Rifabutin-based triple therapy wipes out H. pylori in infected patients

The novel rifabutin-based triple therapy (RHB-105) delivers promising outcomes as first-line empirical treatment for Helicobacter pylori eradication, according to the results of a phase III, double blind trial. This therapy addresses the challenge of rising antibiotic resistance in the current environment.

Hepatitis C infection risk high in MSM on PrEP

Men who have sex with men (MSM) who are on pre-exposure prophylaxis (PrEP) for HIV are at risk of hepatitis C virus (HCV) infections, a new study has found.

Existing interventions reduce psychological distress in staff caring for patients during outbreak

Frontline health workers caring for patients with the novel coronavirus disease (COVID-19) may benefit from effective interventions derived from previous emerging virus outbreaks, which can be employed to help mitigate psychological distress, suggest the results of a rapid review and meta-analysis.

Managing head and neck cancers

Switching to second, third TNFi tied to lower drug survival, response rates in PsA patients

Patients with axial and peripheral psoriatic arthritis (PsA) who switch to a second or third tumour necrosis factor inhibitor (TNFi) have significantly lower drug survival and response rates, a recent study has found.

Use of wearable BP monitors varies according to hypertension management compliance

Compliance to hypertension management affects the likelihood of wearing blood pressure (BP) monitoring devices in older adults, according to a recent China study.

Nivolumab prolongs survival in previously treated gastric/gastroesophageal junction cancer

The immune checkpoint inhibitor nivolumab yields long-term overall survival (OS) gains in treatment-experienced patients with gastric/gastroesophageal junction (G/GEJ), with the benefit most pronounced among those who show a complete (CR) or partial response (PR), according to the 2-year follow-up results of the phase III ATTRACTION-2a study.